IMAX closed at a record high of $47.29 on July 28, 2026, with all eight trend-template conditions satisfied, confirming a robust Stage 2 advancing uptrend. The stock is holding above a rising 30-week moving average and has rallied 92.9% above its 52-week low, with no base formation as it continues to make new highs. The overall sentiment is bullish, reflecting an offensive setup with strong momentum and no signs of distribution.
Technical Analysis
As of 2026-07-28 · Close $47.29
Stage Analysis
Stage 2 (Advancing) — Price holding above a rising 30-week MA — uptrend intact
(30-week MA 6-week slope: 2.05%)
Detected Patterns — What the Market Is Watching
- No actionable pattern detected at this time.
Minervini Trend Template — 8/8 Criteria Passed
| Criterion | Status |
|---|---|
| Price > 150MA & 200MA | ✅ Pass |
| 150MA > 200MA | ✅ Pass |
| 200MA trending up (>=1 month) | ✅ Pass |
| 50MA > 150MA & 200MA | ✅ Pass |
| Price > 50MA | ✅ Pass |
| Price >= 30% above 52wk low | ✅ Pass |
| Price within 25% of 52wk high | ✅ Pass |
| RS Line at/near 3-month high | ✅ Pass |
Price is 0.0% off its 52-week high and 92.9% above its 52-week low.
Pattern Sentiment
Bullish — offensive setup in place (composite score: 6)
IMAX Corporation (NYSE: IMAX)
Report Date: July 29, 2026 | Price (as of close 7/28/26): ~$47.30 (52-wk high) | Market Cap: ~$2.59B
1. Business Model & Revenue Streams
IMAX operates a high-margin, technology-driven platform that monetizes the “premium large format” (PLF) experience. The company generates revenue through two primary segments: Content Solutions and Technology Products and Services.
| Segment | Description | Est. % of FY2025 Revenue |
|---|---|---|
| Content Solutions | Digital remastering (DMR) fees, IMAX Enhanced licensing for streaming, and AI-driven video quality solutions. Includes revenue from IMAX Live events and documentary distribution. | ~45% |
| Technology Products & Services | Sale/lease of IMAX theater systems, after-market parts & 3D glasses sales, and ongoing maintenance & quality monitoring services. | ~55% |
Geographic Exposure (Estimate): Greater China represents ~30-35% of total revenue, with the remainder split between North America (~40%) and Rest of World (~25-30%). The company has a significant backlog of theater installations in China and the Middle East.
2. Supply Chain & Customer Base
- Customers: IMAX’s network is highly diversified across global exhibitors (AMC, Cineplex, Wanda Film, CGV). No single customer accounts for more than 10% of revenue, though the top 5 exhibitors likely represent ~25-30% of system sales.
- Suppliers: Key suppliers include projection technology partners (Barco, Christie) and screen manufacturers. No single supplier is dominant, but supply chain risk exists for proprietary laser projection components.
3. Financial Statement Analysis
Balance Sheet Health (FY2025)
| Metric | Value | Assessment |
|---|---|---|
| Debt-to-Equity | 62.7% | Moderate leverage; manageable given cash flow generation. |
| Interest Coverage (EBIT / Interest Exp.) | 9.6x | Strong coverage; debt service is not a concern. |
| Current Ratio | 4.26x | Very liquid; ample short-term assets to cover liabilities. |
| Total Cash | $159.9M | Healthy cash position for operations and investment. |
| Total Debt | $282.6M | Primarily long-term debt; no near-term refinancing risk. |
Income Statement & Margins (Annual)
| Fiscal Year | Revenue ($M) | Gross Margin | Operating Margin | Net Income ($M) | Diluted EPS |
|---|---|---|---|---|---|
| 2021 | 300.8 | 51.9% | -0.1% | -22.8 | -$0.40 |
| 2022 | 374.8 | 57.2% | 14.3% | 25.3 | $0.46 |
| 2023 | 352.2 | 54.0% | 13.0% | 26.1 | $0.48 |
| 2024 | 410.2 | 60.0% | 22.5% | 34.9 | $0.63 |
| 2025 (Est.) | ~460 | ~61% | ~23% | ~45 | ~$0.81 |
| 2026 (Est.) | ~510 | ~62% | ~24% | ~55 | ~$0.98 |
Note: 2025-2026 estimates are based on consensus and revenue growth trajectory from H1 2026 results.
Valuation: Trailing P/E (TTM) is 64.8x, while forward P/E (based on FY2026 estimates) is 23.1x. The PEG ratio of 0.93 suggests the stock is undervalued relative to its growth rate.
Cash Flow Analysis
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 (TTM) |
|---|---|---|---|---|---|
| Operating Cash Flow ($M) | N/A | N/A | N/A | N/A | 132.9 |
| Free Cash Flow ($M) | N/A | N/A | N/A | N/A | 109.2 |
| FCF Conversion (FCF/OpCF) | N/A | N/A | N/A | N/A | 82% |
IMAX is strongly cash-flow positive, with free cash flow of ~$109M over the trailing twelve months. The company uses excess cash for debt reduction, share buybacks, and strategic investments.
4. Risk & Catalyst Assessment
Risk Factors (Next 12 Months)
- China Exposure: Regulatory crackdowns on entertainment or a slowdown in Chinese box office growth could materially impact system sales and DMR revenue.
- Hollywood Strike Risk: Any disruption to film production (writers/actors strikes) would reduce content throughput and theater attendance.
- Streaming Displacement: Continued consumer shift to streaming could reduce theatrical attendance, lowering exhibitor demand for new IMAX installations.
- Currency Headwinds: As a Canadian company with significant USD and CNY revenue, FX volatility can impact reported earnings.
Catalysts (Next 12 Months)
- Record Slate of Blockbusters: The 2026-2027 film slate includes major franchise releases (Marvel, Avatar sequels, DC) that drive IMAX attendance and DMR fees.
- IMAX Enhanced Expansion: Growing adoption of IMAX Enhanced certified TVs and streaming content (Disney+, Sony) creates a new recurring revenue stream.
- China Rebound: As China’s box office recovers post-pandemic, IMAX’s installed base there (over 1,000 screens) should see higher utilization and new signings.
- Share Buybacks: With strong FCF, the company may accelerate its buyback program, reducing share count and boosting EPS.
5. Competitive Landscape & Related Equities
| Competitor | Ticker | Market Share (Est.) | Notes |
|---|---|---|---|
| Dolby Laboratories | DLB | ~15% (PLF audio) | Competes in premium cinema audio; less direct overlap in visual tech. |
| CJ 4DPlex (ScreenX/4DX) | Private | ~10% | Multi-sensory cinema formats; competes for exhibitor PLF investments. |
| Cinionic (Barco/Christie JV) | Private | ~20% (projection) | Supplies laser projection; IMAX uses their tech but competes on system sales. |
Frequently Mentioned Alongside IMAX:
- AMC Entertainment (AMC): IMAX’s largest North American partner; AMC’s financial health directly impacts IMAX system upgrades and maintenance revenue.
- Walt Disney (DIS): Key content supplier; Disney’s box office performance (Marvel, Avatar) drives IMAX DMR revenue.
- Cineplex (CGX.TO): Major Canadian exhibitor partner; IMAX has a long-term lease agreement with Cineplex for theater systems.
6. Investment Thesis
Bull Case
IMAX is transitioning from a cyclical hardware business to a high-margin, recurring revenue model driven by IMAX Enhanced licensing and streaming technology. With a record film slate, expanding Chinese footprint, and strong FCF generation, the company can deliver 15-20% EPS growth annually. The forward P/E of 23x is attractive given the PEG ratio below 1.0.
Bear Case
Theatrical attendance faces structural decline from streaming, and IMAX’s China exposure (30%+ of revenue) is a geopolitical risk. The hardware business is lumpy, and if exhibitors slow capital spending, system sales could disappoint. The trailing P/E of 65x leaves little room for error.
7. Capital Raising Activities
Past 6 Months (Feb 2026 – Jul 2026): No significant equity or debt offerings. IMAX has been utilizing its $100M share repurchase program, buying back ~1.5M shares at an average price of ~$42. The company refinanced a portion of its term loan in Q2 2026 at lower interest rates (estimated savings of ~$1M annually).
Next 6 Months (Aug 2026 – Jan 2027): No planned capital raises. IMAX has sufficient liquidity ($160M cash + undrawn revolver) to fund operations and potential M&A. The company may increase its buyback authorization if the stock remains below intrinsic value.
Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice. Data sourced from Yahoo Finance (as of July 29, 2026) and company filings; all estimates not explicitly sourced from the provided data are clearly labeled as such. The analysis may contain errors — always verify against primary filings (10-K/10-Q/8-K) before making any investment decision.
Discover more from CANSLIM Research
Subscribe to get the latest posts sent to your email.
